NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 60 filers reported holding NOVOCURE LTD in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411,786 | -66.2% | 21,314 | +29.9% | 0.00% | – |
| Q2 2023 | $1,216,696 | +24.1% | 16,413 | +24.8% | 0.00% | – |
| Q4 2022 | $980,367 | -45.9% | 13,154 | -36.3% | 0.00% | -100.0% |
| Q3 2022 | $1,813,000 | +22.9% | 20,635 | +1.7% | 0.00% | 0.0% |
| Q2 2022 | $1,475,000 | -15.7% | 20,298 | -1.1% | 0.00% | 0.0% |
| Q1 2022 | $1,750,000 | +11.7% | 20,517 | +4.9% | 0.00% | 0.0% |
| Q4 2021 | $1,567,000 | -89.8% | 19,560 | -83.8% | 0.00% | -85.7% |
| Q3 2021 | $15,385,000 | +260.0% | 120,601 | +532.6% | 0.01% | +250.0% |
| Q2 2021 | $4,274,000 | +101.9% | 19,064 | +19.3% | 0.00% | +100.0% |
| Q1 2021 | $2,117,000 | -22.8% | 15,977 | -0.9% | 0.00% | -50.0% |
| Q4 2020 | $2,742,000 | +48.2% | 16,119 | +4.1% | 0.00% | 0.0% |
| Q3 2020 | $1,850,000 | -35.0% | 15,491 | -67.3% | 0.00% | -33.3% |
| Q2 2020 | $2,844,000 | -8.8% | 47,357 | +0.7% | 0.00% | -25.0% |
| Q1 2020 | $3,117,000 | -52.6% | 47,029 | -39.7% | 0.00% | -20.0% |
| Q4 2019 | $6,576,000 | +123.0% | 78,038 | +97.9% | 0.01% | +66.7% |
| Q3 2019 | $2,949,000 | +0.5% | 39,434 | -15.0% | 0.00% | +50.0% |
| Q2 2019 | $2,934,000 | +327.7% | 46,397 | +225.6% | 0.00% | +100.0% |
| Q1 2019 | $686,000 | +24.7% | 14,249 | -13.1% | 0.00% | 0.0% |
| Q4 2018 | $550,000 | -42.9% | 16,395 | -10.9% | 0.00% | 0.0% |
| Q3 2018 | $963,000 | +228.7% | 18,394 | +96.1% | 0.00% | – |
| Q2 2018 | $293,000 | +90.3% | 9,379 | +32.7% | 0.00% | – |
| Q1 2018 | $154,000 | +7.7% | 7,069 | 0.0% | 0.00% | – |
| Q4 2017 | $143,000 | +2.1% | 7,069 | 0.0% | 0.00% | – |
| Q3 2017 | $140,000 | +14.8% | 7,069 | 0.0% | 0.00% | – |
| Q2 2017 | $122,000 | +3966.7% | 7,069 | +1919.7% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | -25.0% | 350 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | -20.0% | 350 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | – | 350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |